Celltrion
068270.KS
#771
Rank
โ‚น2.813 T
Marketcap
โ‚น12,861
Share price
1.48%
Change (1 day)
26.25%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): โ‚น165.10

According to Celltrion 's latest financial reports the company's current EPS (TTM) is โ‚น178.60. an increase over its 2024 EPS that were of โ‚น116.12.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025โ‚น306.16163.66%
2024โ‚น116.12-53.73%
2023โ‚น250.97-2.08%
2022โ‚น256.30-11.72%
2021โ‚น290.332.03%
2020โ‚น284.5482.8%
2019โ‚น155.6518.31%
2018โ‚น131.56-36.33%
2017โ‚น206.65161.25%
2016โ‚น79.102.86%
2015โ‚น76.9017.84%
2014โ‚น65.265.87%
2013โ‚น61.64-70.85%
2012โ‚น211.46134.09%
2011โ‚น90.3343.59%
2010โ‚น62.9174.49%
2009โ‚น36.05317.8%
2008โ‚น8.63-71.7%
2007โ‚น30.49